O'Brien James Michael 4
4 · ENZO BIOCHEM INC · Filed Jan 4, 2019
Insider Transaction Report
Form 4
O'Brien James Michael
SVP of Finance
Transactions
- Award
Stock Option (to acquire common stock)
2019-01-03+52,000→ 33,666 totalExercise: $2.80From: 2020-01-04Exp: 2024-01-02→ Common Stock (52,000 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted 52,000 stock options. The options have a five-year term and shall vest in three equal annual tranches, beginning January 4, 2020.
- [F2]Does not include 10,500 Restricted Stock Units granted to the Reporting Person on January 3, 2019, which will vest, if at all, based upon (i) achievement of average revenue growth and adjusted EBITDA growth goals on January 3, 2022, and (ii) the continued service of the Reporting Person through January 3, 2022.